Methadone Associated With Morphine for Cancer Pain

F

Federal University of São Paulo

Status

Unknown

Conditions

Cancer

Treatments

Drug: Methadone
Drug: Morphine

Study type

Interventional

Funder types

Other

Identifiers

NCT03324815
30850414.0.0000.5505

Details and patient eligibility

About

The study was prospective, randomized. Patients with cancer pain were evaluated, one group receiving methadone with morphine and another group receiving morphine as the only opioid. Pain intensity, total morphine dose and adverse effects were evaluated.

Full description

Opioids are the most important analgesics for the relief of cancer pain. In addition tolerance and hyperalgesia may ocurr as a consequence of treatment with these drugs. Medications for pain relief may also cause increased pain. NMDA receptor blockers may prevent or reduce the development of hyperalgesia. Methadone is a weak NMDA receptor antagonist and therefore its association could prevent hyperalgesia. The primary endpoint of the study was whether the administration of low dose methadone associated with morphine promotes better analgesic effect in patients with cancer pain, And secondarily to assess whether there is a reduction in the total dose of opioid needed for pain relief, and whether reduction of the opioid-related adverse effects occurs.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Approved by the Ethics Committee
  • signed the informed consent
  • cancer pain
  • starting the WHO thirth analgesic ladder,

Exclusion criteria

  • cognitive impairment
  • psychiatric disease
  • illicit drug user
  • hypersensitivity to the study drugs
  • pregnant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Morphine- Methadone
Active Comparator group
Description:
Morphine 5mg/6h plus metadone: 2,5mg/12h
Treatment:
Drug: Morphine
Drug: Methadone
Morphine
Active Comparator group
Description:
Morphine: 5mg/6h
Treatment:
Drug: Morphine

Trial contacts and locations

0

Loading...

Central trial contact

Feliciano NC Duarte, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems